razormd

Adventrx Plummets 80% On Cancer Drug Trial Results

ANX is a joke...ANX-530???...do you even know what it is?...basically it is navelbine...despite ANX claims, vein "toxicity" isn't even considered a serious adverse effect for Navelbine!...chemical phlebitis is reported in only 10% of the patients receiving Navelbine!...and Navelbine is used to treat advanced, unresectable non-small cell lung cancer -- in other words, patients with very little time left...and what's the market for Navelbine?...maybe a hundred million dollars?...wow, a relatively tiny market that has practically no need for what ANX claims ANX-530 has to offer...then from ANX's website:

"This new formulation emulsifies vinorelbine into a homogeneous suspension of nanoparticles..."

...nanoparticles?!!...... YUK!!...that's rich!!...reduces vein toxicity?...they conclude that on the basis of a single preclinical study of rabbit ear veins?!...oh, please, I'm starting to hurt!!...they don't even have a copy of the poster presentation on their website -- they probably don't want anynone looking too closely...more to the point, has anyone asked whether there is a market for this "nanoparticle" formulation?...quick answers: no they haven't and no there isn't...and given their extraordinary success with getting what's little more than a B-vitamin approved, how likely will they succeed with a real, honest-to-God drug?...it's pathetic how low some of these companies will go to try and corral sheep for shearing.